Every year, up to 8 million children in the world are born with birth defects. Newborn screening programs aim to detect metabolic disorders in children early, helping to prevent dangerous complications and giving children a normal, healthy life.

Performing postnatal screening 24-72 hours after birth by taking blood from the baby's heel helps doctors screen for certain genetic diseases and metabolic disorders in children, reducing the number of children with physical and mental retardation and many other diseases.

Heel blood sampling is part of the newborn screening program for babies to detect early endocrine diseases and metabolic disorders that affect the health and physical and mental development of children. Especially dangerous diseases that are difficult to detect clinically at birth.

Taking blood from the heel and screening newborns within the first 48 hours after birth will help detect birth defects early, preventing serious consequences of birth defects for children.